logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12208072 B1

PDFFull Text
Date of Patent:
Jan. 28, 2025

Filed:

Feb. 13, 2019

Compositions for removing necrotic or infected tissues from body surface lesions and from oral cavity

Applicant:

Debx Medical Holding B.v., Rotterdam, NL;

Inventors:

Carlo Alberto Bignozzi, Ferrara, IT;

Francesco Carinci, Bologna, IT;

Alberto Cogo, Vicenza, IT;

Assignee:

DEBx Medical Holding B.V., Rotterdam, NL;

Attorney:

N.V. Nederlandsch Octrooibureau

Primary Examiner:

Sarah Pihonak

Int. Cl.
CPC ...
A61K 31/185 (2006.01); A61K 9/00 (2006.01); A61K 31/10 (2006.01); A61K 31/191 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 31/4184 (2006.01); A61K 31/695 (2006.01); A61K 31/77 (2006.01); A61K 33/00 (2006.01); A61P 1/02 (2006.01); A61P 17/02 (2006.01); A61P 31/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/185 (2013.01); A61K 9/0063 (2013.01); A61K 31/10 (2013.01); A61K 31/191 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 31/4184 (2013.01); A61K 31/695 (2013.01); A61K 31/77 (2013.01); A61K 33/00 (2013.01); A61P 1/02 (2018.01); A61P 17/02 (2018.01); A61P 31/04 (2018.01);
Abstract

A composition, usable for removing a biofilm and necrotic or infected tissues from skin lesions and lesions of the oral cavity, comprises methanesulfonic acid 99.0% and a proton acceptor. The proton acceptor is selected from the group consisting of: anhydrous sodium carbonate, 5-amino-2-mercaptobenzimidazole, ethylenediaminetetraacetic acid tetrasodium salt, sodium gluconate, sodium tartrate dihydrate, 2-mercapto-5-benzimidazole sodium sulfonate, dimethyl sulfoxide, polyethylene glycol 400, polyethylene glycol 600, silicon dioxide, tetraethoxysilane, and mixtures thereof. The aforesaid composition can be prepared in the form of a solution, gel or cream.

Find Patent Forward Citations

Loading…